Published On: Sep 16, 2020

The Russian Direct Investment Fund has collaborated with Indian pharma giant Dr Reddy's Laboratories to conduct clinical trials of the Sputnik V vaccine against COVID-19 as well as its distribution, RDIF CEO Kirill Dmitriev said on Wednesday. The RDIF is in talks with Indian regulators to ensure that all the requirements for clinical trials are being met, he said.  

Related Videos

Entertainment Articles